Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wright

Showing results (1031-1040 of 1,274) with videos related to

Pageof 128
Sort By:
ACS Nano|December 24, 2015
Tools for the Microbiome: Nano and BeyondJulie S Biteen, Paul C Blainey, Zoe G Cardon, et al.
Neurobiology of Disease|September 23, 2025
Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndromeCherie A Stringer, Haley K S Miyasato, Kevin A Camey, et al.
Cureus|April 17, 2023
A Medicaid Statewide Hypertension Quality Improvement Project: Initial ResultsShari D Bolen, Siran Koroukian, Jackson T Wright, et al.
Acta Neuropathologica|March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespanJesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
The New England Journal of Medicine|November 12, 2013
APOL1 risk variants, race, and progression of chronic kidney diseaseAfshin Parsa, W H Linda Kao, Dawei Xie, et al.
Journal of the American Geriatrics Society|December 17, 2019
Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention TrialNicholas M Pajewski, Dan R Berlowitz, Adam P Bress, et al.
Journal of Medicinal Chemistry|October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonistsIldiko M Buck, James W Black, Tracey Cooke, et al.
JAMA|May 20, 2016
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical TrialJeff D Williamson, Mark A Supiano, William B Applegate, et al.
Kidney International|June 26, 2016
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volumeBarry I Freedman, Crystal A Gadegbeku, R Nick Bryan, et al.
Science (New York, N.Y.)|November 30, 2023
A Neptune-mass exoplanet in close orbit around a very low-mass star challenges formation modelsGuðmundur Stefánsson, Suvrath Mahadevan, Yamila Miguel, et al.
Pageof 128

Showing results (1031-1040 of 1,274) with videos related to

Sort By:
Pageof 128
ACS Nano|December 24, 2015
Tools for the Microbiome: Nano and BeyondJulie S Biteen, Paul C Blainey, Zoe G Cardon, et al.
Neurobiology of Disease|September 23, 2025
Regional differences in astrocytic Aquaporin-4 protein levels and distribution in aging and Alzheimer's disease in down syndromeCherie A Stringer, Haley K S Miyasato, Kevin A Camey, et al.
Cureus|April 17, 2023
A Medicaid Statewide Hypertension Quality Improvement Project: Initial ResultsShari D Bolen, Siran Koroukian, Jackson T Wright, et al.
Acta Neuropathologica|March 22, 2026
Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespanJesse R Pascual, Isabel Rivera, Halyma Nguyen, et al.
The New England Journal of Medicine|November 12, 2013
APOL1 risk variants, race, and progression of chronic kidney diseaseAfshin Parsa, W H Linda Kao, Dawei Xie, et al.
Journal of the American Geriatrics Society|December 17, 2019
Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention TrialNicholas M Pajewski, Dan R Berlowitz, Adam P Bress, et al.
Journal of Medicinal Chemistry|October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonistsIldiko M Buck, James W Black, Tracey Cooke, et al.
JAMA|May 20, 2016
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical TrialJeff D Williamson, Mark A Supiano, William B Applegate, et al.
Kidney International|June 26, 2016
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volumeBarry I Freedman, Crystal A Gadegbeku, R Nick Bryan, et al.
Science (New York, N.Y.)|November 30, 2023
A Neptune-mass exoplanet in close orbit around a very low-mass star challenges formation modelsGuðmundur Stefánsson, Suvrath Mahadevan, Yamila Miguel, et al.
Pageof 128